Unusual Machines Lands Major U.S. Army Drone Order

By Hao Liu • Thursday, October 16 06:05 • Permanent Link

Unusual Machines, Inc. (NYSE American: UMAC) has secured a significant order from the U.S. Army's 101st Airborne Division for 3,500 NDAA-compliant motors to support the deployment of the new Attritable Battlefield Enabler (A.B.E.) V1.01 drones. This order also includes other U.S.-made, NDAA-compliant, and Blue UAS-listed components such as the Aura analog camera, Aura VTX, Brave flight controller, and Brave ESC.

The U.S. Army has expressed plans to expand procurement, with an additional order of 20,000 components, including motors, from Unusual Machines in 2026, indicating a strong demand for the company's products.

Chief Warrant Officer 4 John Brown, from the Robotics, Automation & Innovation Directorate for the 101st Airborne Division, highlighted the importance of supporting American businesses, emphasizing the reliability and compliance of the drones, which are priced under $1,000.

Stacy Wright, Executive Vice President of Revenue at Unusual Machines, emphasized the value of investing in U.S. manufacturing and compliance, underlining that the motors produced at the new facility meet both the Army's requirements and the broader push for U.S.-based production.

This order signifies a significant achievement for Unusual Machines, showcasing their ability to meet stringent compliance standards and support the U.S. military's technological advancements in drone capabilities. As a result of these announcements, the company's shares have moved 6.21% on the market, and are now trading at a price of $15.21. For the full picture, make sure to review Unusual Machines's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.